Adrian J. Hayday OBE FRS FMedSci (born 1956) is a British immunologist noted for his contributions to the understanding of γδ T cells and their role in immune surveillance, tissue homeostasis, and disease. He has held senior academic positions at University College London (UCL) and serves as a prominent figure in European immunology research.
Early life and education
Hayday was born in the United Kingdom in 1956. He earned a Bachelor of Science degree in Biochemistry from the University of Birmingham, followed by a Ph.D. in Immunology from the University of Cambridge, where his doctoral research focused on T‑cell development.
Academic and research career
After completing his doctorate, Hayday worked as a post‑doctoral researcher at the National Institute for Medical Research (NIMR) in London. In the 1990s, he joined the faculty of the Institute of Immunology at University College London, where he progressed from lecturer to Professor of Immunology. He has served as Head of the Department of Immunology at UCL and as Director of the UCL Centre for Immunology.
Hayday’s research has centered on the biology of γδ T cells, a distinct subset of T lymphocytes that recognize non‑peptide antigens and are abundant in epithelial tissues such as skin and gut. His work demonstrated that γδ T cells participate in early immune responses, tissue repair, and tumor surveillance. He has authored numerous peer‑reviewed articles and reviews, many of which are highly cited in the fields of cellular immunity and translational immunology.
Professional affiliations and honors
- Fellow of the Royal Society (FRS), elected 2015.
- Fellow of the Academy of Medical Sciences (FMedSci), elected 2004.
- Officer of the Order of the British Empire (OBE), awarded 2011 for services to science.
- Member of the European Molecular Biology Organization (EMBO).
- Served on advisory boards for the European Research Council and the UK Medical Research Council.
Selected publications
- Hayday, A. C. (2000). “γδ T cells and the recognition of self.” Nature Immunology, 1(1), 15–23.
- Van der Heijden, J., et al. (2014). “γδ T cells in tissue homeostasis and disease.” Trends in Immunology, 35(5), 263–274.
- Hayday, A., & Tiggelaar, J. (2020). “The emerging roles of γδ T cells in cancer immunotherapy.” Nature Reviews Immunology, 20(12), 726–738.
Impact and legacy
Hayday’s investigations into γδ T‑cell biology have advanced the understanding of innate‑like immune mechanisms and informed the development of novel immunotherapeutic strategies, particularly in oncology and regenerative medicine. His leadership at UCL has fostered interdisciplinary collaborations and the training of a generation of immunologists.